Found 6 matching trials
Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma PHASE2 This randomized phase II trial is studying how well giving vaccine therapy ...
Show More Location
National Cancer Institute Surgery Branch
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye PHASE2 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Learn More & Join Trial
Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma PHASE1 RATIONALE: Drugs used in chemotherapy, such as fludarabine, work in differe...
Show More Location
Providence Cancer Center at Providence Portland Medical Center
Learn More & Join Trial
Peptide Vaccination for Patients at High Risk for Recurrent Melanoma PHASE2 This study will examine the effectiveness and side effects of an experiment...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial
Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma PHASE3 This randomized phase III trial studies aldesleukin with vaccine therapy to...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery PHASE1 RATIONALE: Vaccines made from peptides may help the body build an effective...
Show More Location
UPMC Cancer Centers
Learn More & Join Trial